Food & Food Contact Materials
CIRS Group
Medical Devices
C&K Testing
Carbon Neutrality
In the first quarter of 2024, according to the European Food Safety Authority (EFSA) and the Official Journal of the European Union, EFSA published assessment results for 6 Novel Foods, including applications for 4 new Novel Foods, notification on 1 new traditional food from a third country and the modification of 1 novel food already authorized. Additionally, EFSA requested scientific and technical assistance as regards the evaluation of 1 Novel Food, and there were no new authorizations (approvals) for Novel Food in the EU in the first quarter of 2024.
In the first quarter of 2024, the official website of the FDA updated the GRAS status of 27 products. Among these, approval was granted for 2 substances, 2 substances ceased to be evaluated at the notifier’s request, and 23 substances are still pending after submission. This article provides a summary of the US FDA GRAS acceptance and approval status in the first quarter of 2024, for the information and reference of businesses.
From April 7 to April 14, 2024, the National Health Commission (NHC) Government Services Platform issued notifications for the approval and review of “three new foods” (new food raw materials, new food additives, and new food-related products). This includes delivering an extension notice for 1 new food raw material and issuing a non-approval decision on 1 new food-related product.
The Chinese session was hosted on April 2 and many questions were raised during the training. We have collected the questions and made a Q&A summary for your reference
On April 3, 2024, in accordance with the Measures for the Registration of Food for Special Medical Purpose (Announcement No. 85) issued by the State Administration for Market Regulation (SAMR), the Center for Food Evaluation (CFE) has reviewed the registration applications for FSMP seeking priority review and approval, and is now making public the proposed FSMP for the priority process. The public notice period will be in effect for 5 working days.
According to the State Administration for Market Regulation (SAMR), the number of foods for special medical purposes (FSMP) approved in China has reached 181. 17 FSMPs have been approved in the first quarter of 2024, including 16 domestic products and 1 imported. These include 3 domestic nutritionally complete products, 8 domestic nutritionally incomplete products, 5 domestic infant formula for special medical purposes, and 1 imported infant formula for special medical purposes.
To standardize and guide the food additives production licensing work, and strengthen the safety supervision of food additives, the State Administration for Market Regulation (SAMR) drafted and issued the Review Rules for the Production Licence of Food Additives (Draft) for public comments. Comments are welcomed before May 3, 2024.
Detailed information on 181 registered FSMP products
In response to consumer complaints about difficulties finding, reading, and calculating the production dates and shelf lives of pre-packaged foods, the State Administration for Market Regulation (SAMR), in accordance with the Food Safety Law of the People’s Republic of China and relevant standards and regulations, recently issued Announcement on Encouraging Food Enterprises to Improve the Labeling of Production Dates and Shelf Lives of Pre-packaged Foods (hereinafter referred to as the Announcement) to address these concerns.
From our years of regulatory compliance experience, we’ve translated a selection of some frequently asked questions on foods for special medical purposes (FSMP) to help you gain a clearer understanding of the current requirements in China.